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Abstract
The efficacy of biological therapeutics against cartilage degradation in osteoarthritis is restricted
by the limited transport of macromolecules through the dense, avascular extracellular matrix. The
availability of biologics to cell surface and matrix targets is limited by steric hindrance of the
matrix, and the microstructure of matrix itself can be dramatically altered by joint injury and the
subsequent inflammatory response. We studied the transport into cartilage of a 48 kDa anti-IL-6
antigen binding fragment (Fab) using an in vitro model of joint injury to quantify the transport of
Fab fragments into normal and mechanically injured cartilage. The anti-IL-6 Fab was able to
diffuse throughout the depth of the tissue, suggesting that Fab fragments can have the desired
property of achieving local delivery to targets within cartilage, unlike full-sized antibodies which
are too large to penetrate beyond the cartilage surface. Uptake of the anti-IL-6 Fab was
significantly increased following mechanical injury, and an additional increase in uptake was
observed in response to combined treatment with TNFα and mechanical injury, a model used to
mimic the inflammatory response following joint injury. These results suggest that joint trauma
leading to cartilage degradation can further alter the transport of such therapeutics and similar-
sized macromolecules.
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1. Introduction
Proinflammatory cytokines are key mediators involved in the pathogenesis of both
osteoarthritis (OA) and rheumatoid arthritis (RA). The roles of predominant cytokines in
cartilage destruction have been extensively studied in efforts to find effective therapeutic
targets for these arthritic diseases [1, 2]. Monoclonal antibodies against specific cytokines
such as TNFα and IL-6 are now administered to RA patients by systemic infusion or
subcutaneous injection [3, 4]. Following the success of these biological therapies for RA,
similar approaches have been under study to target selected cytokines for OA [1, 2].
However, since OA involves the local pathophysiology of specific joint tissues, systemic
administration of biologics may not be efficacious and may increase the risk of side effects
[5]. Intra-articular (IA) injection directly to affected joints is therefore advantageous, and
may better control the concentration of a desired drug in the joint space.
Despite the potential benefits of IA injection, the effect of biologics against cartilage
degradation in OA is significantly compromised by limited transport into and through the
tissue's dense extracellular matrix (ECM). Previous studies by Maroudas showed that large
solutes are sterically excluded by ECM proteoglycans (mainly aggrecan), and that full-size
immunoglobulin (IgG) antibodies (150 kDa) cannot penetrate into cartilage ECM to reach
cellular therapeutic targets [6]. Since the extent of steric hindrance by the ECM depends on
the size of solute, smaller-sized antibody fragments (e.g., 48 kDa Fab fragments or 26 kDa
single-chain Fv (ScFv)), should be able to penetrate the ECM while maintaining their
biological activity. For example, a ScFv against TNFα showed a similar inhibitory effect but
also an increased tissue penetration compared to its full-sized counterpart [7]. 40 kDa
dextrans, which have similar molecular weight to Fab fragments, are capable of diffusing
into cartilage [8–10]. However, to our knowledge, there has been no direct study of the
transport of Fab antibodies into and within cartilage. Thus, the ability of a Fab to reach intra-
cartilage targets as a potential OA therapeutic has not been confirmed.
Recent attention to the role of IL-6 in post-traumatic OA has motivated the potential use of
anti-IL-6 therapeutics for OA [1]. Sui and co-workers showed that GAG loss from cartilage
explants induced by the combination of mechanical injury and co-incubation with TNFα in
vitro was reduced by treatment with an anti-IL-6 Fab fragment [11]. Thus, upregulation of
endogenous IL-6 by these degradative stimuli was responsible in part for the observed
cartilage degradation. However, it was not known whether the partial effectiveness of the
anti-IL-6 Fab was associated with transport limitations into the tissue. In addition, transport
of macromolecular solutes into cartilage can be dramatically affected by binding of the
solutes to sites in the ECM; the resulting diffusion-reaction transport kinetics can lead to an
effective solute diffusivity that is orders of magnitude lower than that in the absence of
binding [12]. Therefore, studies of Fab transport into cartilage should examine the
possibility of binding of the Fab within the ECM.
Damage to cartilage following traumatic joint injury and the subsequent inflammatory
response in vivo may alter the cartilage transport properties, since matrix hindrance to
molecular transport will be affected by changes in the structure, composition and hydration
of cartilage ECM [6, 9, 13]. Such changes in ECM transport properties caused by combined
mechanical injury and inflammatory cytokines have not been studied in detail. Several
groups have used ECM proteolysis in vitro, e.g., using trypsin, to mimic cartilage
degeneration, and found increased solute diffusivity and partition coefficient after GAG loss
[14–18]. However, injurious compression as occurs during joint trauma [19] additionally
causes tissue swelling, collagen damage and denaturation, GAG loss, and decreased ECM
integrity [20]. Furthermore, the interaction between exogenous cytokines and cartilage
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mechanical injury is known to cause synergistic loss of proteoglycans which, taken together,
suggest the possibility of substantial changes in tissue transport properties [11, 20–26].
Motivated by these previous reports, the objectives of this study were (1) to quantify the
transport of anti-IL-6 Fab fragment in articular cartilage, and (2) to characterize the changes
in transport of anti-IL-6 Fab following mechanical injury and simultaneous treatment with
the inflammatory cytokine TNFα. Diffusive transport of Fab was quantified and its spatial
distribution in cartilage tissue was visualized. A competitive binding assay was performed to
confirm whether or not the anti-IL-6 Fab could bind to cartilage ECM. Changes in transport
of the anti-IL-6 Fab were compared to measured changes in tissue hydration and GAG
density.
2. Materials and Methods
Bovine tissue harvest
Bovine articular cartilage explants were harvested from the femoropatellar grooves of 1–2
weeks old calves (Research 87, Marlborough, MA) as described previously [27]. A total of
12 joints from 6 different animals were used. Briefly, 9-mm diameter cartilage-bone
cylinders were drilled perpendicularly to the surface and mounted on a microtome. After
obtaining a level surface by removing the top superficial layer, 1–2 sequential 1-mm thick
middle zone slices were cut. Finally, four or five disks (3-mm diameter, 1-mm thick) were
cored from each slice using a dermal punch. Explants were matched for location and depth
across treatment groups. All cartilage specimens were equilibrated either in serum-free
medium (low-glucose Dulbecco's modified Eagle's medium [DMEM; 1 g/L]) supplemented
with 1% insulin-transferrin-selenium (10 μg/mL, 5.5 μg/mL, and 5 ng/mL, respectively)
(Sigma, St. Louis, MO), 10 mM HEPES buffer, 0.1 mM nonessential amino acids, 0.4 mM
proline, 20 μg/mL ascorbic acid, 100 units/mL penicillin G, 100 μg/mL streptomycin, and
0.25 μg/mL amphotericin B in a 37°C, 5% CO2 incubator or in 1× phosphate buffered saline
(PBS) supplemented with 0.1% bovine serum albumin (BSA), 0.01% sodium azide (NaN3)
and protease inhibitors (Complete, Roche Applied Science, Indianapolis, IN) at 4°C prior to
experiments.
Postmortem adult human tissue
A knee joint from a human subject (26-year-old woman) was obtained 36 hr postmortem
from the Gift of Hope Organ and Tissue Donor Network (Elmhurst, IL). All procedures
were approved by the Office of Research Affairs at Rush–Presbyterian–St. Luke's Medical
Center and the Committee on Use of Humans as Experimental Subjects at Massachusetts
Institute of Technology. All joint surfaces of this knee joint were scored according to
modified Collins scale [28] as grade 0–1, and only cartilage from visually unfibrillated areas
were harvested for this study. After coring 3-mm diameter cartilage disks from the
femoropatellar groove and femoral condyles using a dermal punch, 0.8-mm thick slices were
cut from the top-most surface including the intact superficial zone. These human cartilage
disks (3-mm diameter, 0.8-mm thick) were cultured using the same methods as above for
bovine tissue, except that culture medium for human tissue contained high-glucose DMEM
(4.5 g/L) and 1 mM sodium pyruvate.
Solute preparation
Iodinated 48 kDa Fab fragment (125I-Fab) and unlabeled Fab raised against the
inflammatory cytokine, IL-6, were kindly provided by Janssen Research & Development,
LLC [11]. Before performing experiments with the 125I-Fab, Sephadex G50 chromatography
was used to separate and remove any small 125I-species that may have resulted from
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degradation of 125I-Fab (0.7 × 50 cm gravity-fed column equilibrated in 1×PBS with 0.1%
BSA and 0.01% NaN3, and the void volume collected to obtain the purified 125I-Fab) [12].
Measurement of 125I-Fab uptake into bovine cartilage
In order to measure the partitioning of Fab fragments into cartilage, free-swelling bovine
calf cartilage disks were incubated at 4°C up to 8 days in a buffer containing 125I-Fab (5.01
nM) without unlabeled Fab. Multi-well plates containing equilibration baths and cartilage
explants were placed on a rocker to maintain continuously well-mixed conditions. The
amount of Fab in cartilage disks was quantified using an uptake ratio calculated as the
measured concentration of 125I-Fab in the disks (per intratissue water weight) normalized to
the concentration of 125I-Fab in the equilibration bath [12, 29]. The buffer consisted of
1×PBS supplemented with 0.1% BSA, 0.01% NaN3 and protease inhibitors (Complete,
Roche Applied Science, Indianapolis, IN). At selected time points, disks were collected
from the bath and briefly rinsed in fresh PBS. The surface of each disk was quickly blotted
with Kimwipes and the wet weight was measured. The amount of 125I-radioactivity of each
disk and aliquots of the equilibration baths were measured individually using a gamma
counter (model B5002, Packard Instrument Company, Meriden, CT). Disks were then
lyophilized and the dry weight was measured. Water weight was then calculated as the
difference of wet and dry weights. To take into account the accumulation of any small
labeled species (e.g., 125I) from the degradation of 125I-Fab during each experiment and
correct the uptake ratio for the presence of these small species, samples of the equilibration
baths were analyzed by Sephadex G50 chromatography at the end of each experiment.
Assuming the small species to be 125I, the uptake ratio of 125I alone was measured in
separate experiment to calibrate the correction factor [30].
Autoradiography of human cartilage disks
Free swelling human cartilage disks with intact superficial zone were incubated with 125I-
Fab with no unlabeled Fab at 37°C for 3 days in 1×PBS supplemented with 0.1% BSA,
0.01% NaN3 and protease inhibitors. Collected cartilage disks at the end of experiment were
flash-frozen in liquid nitrogen and kept frozen at −80°C. Briefly, slides containing
cryosections of 5 μm thickness were dipped into Kodak NTB-2 emulsion, followed by
drying at room temperature, and exposure at 4°C for up to 3 weeks. After the exposure
period, the slides were developed in Kodak D-19 developer. Each slide was lightly section-
stained with 0.001% toluidine blue in buffer (2% boric acid, 1% sodium tetraborate, pH 7.6)
and viewed by light microscopy using ×10 and ×40 objectives [31]. To quantify the depth-
dependence of autoradiography grain intensity, images were converted to grayscale,
inverted, and 20–40 μm wide vertical sections of the images were chosen that avoided cells.
Within these sub-images, grains in each horizontal row were summed to calculate a relative
grain density as a function of depth. The resulting densitometry data were smoothed using a
running average algorithm with a window size of approximately 40 μm.
Concentration dependent uptake ratio
To determine whether Fab may bind to sites within the bulk of the tissue, bovine calf
cartilage disks under free-swelling condition were incubated in a buffer containing 125I-Fab
(5.01 nM for experiments at 4°C and 2.21 nM for experiments at 37°C) with graded
amounts of unlabeled Fab (0, 10, 100, and 1000 nM). The uptake ratio was measured at 4°C
as well as 37°C since the studies at 4°C provide measurements under conditions when
potential effects of matrix degradation, cellular activity and artifactual degradation of
iodinated proteins over time are minimized. The buffer consisted of 1×PBS with 0.1% BSA,
0.01% NaN3 and protease inhibitors at 4°C or DMEM with 1% ITS and 0.1% BSA at 37°C.
Cartilage disks were incubated for 5 days and the uptake ratio at each condition was
quantified as described above.
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Effecst of injurious compression on uptake ratio and tissue swelling
Bovine calf cartilage disks were subjected to a single injurious compression in a custom-
designed, incubator-housed loading apparatus [20, 32]. Briefly, each individual disk was
placed between impermeable platens of a polysulfone chamber, in a radially unconfined
compression configuration. During injury loading, the disk was compressed to 50% final
strain with a constant velocity of 1 mm/s (strain rate 100%/s) and then immediately released
at the same rate. This injury protocol resulted in a peak stress of ~ 20 MPa, which is known
to produce ECM damage, reduced mechanical properties, decreased biosynthesis, increased
GAG loss to media, and approximately 10–20% cell death [20–23]. Untreated and injured
cartilage disks were then incubated under free swelling conditions for 6 days with 125I-Fab
without unlabeled Fab at 4°C in 1×PBS with 0.1% BSA, 0.01% sodium azide, and protease
inhibitors. At the end of experiment, disks were collected to measure the uptake ratio. Wet
and dry weights of cartilage disks were used to calculate tissue hydration and water content.
Tissue hydration was defined as tissue water weight (mg) normalized by dry weight (mg).
Effects of exogenous cytokines combined with mechanical injury
To test the effect of exogenous cytokines combined with mechanical injury on the uptake
of 125I-Fab, bovine calf cartilage disks were subjected to no treatment (control), mechanical
injury, exogenous TNFα (R&D Systems, Minneapolis, MN), or the combination of injury
and TNFα. Uptake of 125I-Fab in these same four conditions was then measured under
conditions of sustained 10% static compression: normal or mechanically injured 3-mm
diameter × 1-mm thick bovine disks were first compressed by 10% in the same loading
chamber, then incubated with 125I-Fab plus unlabeled Fab (10 μg/ml) with or without TNFα
(2.5 ng/ml for day 0–2, 25 ng/ml for day 2–6). Under 10% offset static compression, only 1-
dimensional (radial) diffusion was allowed from the bath to the disk center. The medium
was replaced every 2 days and saved for further analysis. At day 2, 4, and 6, disks were
collected and processed to measure the uptake ratio. Disks were then digested with
proteinase-K (Roche Applied Science, Indianapolis, IN). The dimethylmethylene blue
(DMMB) dye binding assay was used to measure the sulfated glycosaminoglycan (sGAG)
content of each disk and also the amount sGAG release from the disk to the media [27].
Statistical Analysis
Two-way ANOVA was used to test the effects of unlabeled Fab concentration and
temperature on the uptake. The effect of injurious compression on the uptake ratio and tissue
swelling was tested with two-way ANOVA using the injury and time as factors. The effects
of mechanical injury and TNFα on the uptake ratio, tissue hydration, and GAG density were
evaluated by two-way ANOVA, followed by post-hoc Tukey test. For all statistical test, p-
values less than or equal to 0.05 were considered significant. Systat 12 software (Richmond,
CA) was used to perform all analyses.
3. Results
Anti-IL-6 Fab fragment (48 kDa) was able to penetrate into cartilage explants
The uptake of 125I-Fab was measured daily during a 9-day incubation of middle zone bovine
disks to evaluate the ability of the fab fragment to penetrate into cartilage by simple
diffusion (Fig. 1). The uptake ratio of 125I-Fab increased continuously, suggesting the
accumulation of the solute within the disk. Due to its large size, diffusion of the Fab was
relatively slow, similar to that reported previously for other similarly sized solutes [6].
However, the time-dependent increase in uptake ratio does not necessarily mean full
penetration of Fab fragment beyond the outer surfaces of the explant disks. Non-specific
binding or adsorption to the outer surfaces could also result in an apparent increase in the
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accumulation of 125I-Fab [33], leading to an increase in calculated uptake measurement
whether or not the Fab penetrated into deeper regions of the tissue. To confirm qualitatively
whether 125I-Fab could diffuse more deeply into the tissue, the spatial distribution of 125I-
Fab was visualized by autoradiography (Fig. 2). Human knee cartilage disks including the
intact superficial zone were incubated with 125I-Fab without unlabeled Fab at 37°C for 3
days; 125I-Fab could thereby enter the disks from the top and the bottom surfaces.
Autoradiography revealed that 125I-Fab was detectable throughout the tissue at day 3,
though there was still a pronounced gradient in the grain density which was higher in the
superficial zone than the deeper zones (Fig. 2). This observation is qualitatively consistent
with the known higher concentration of aggrecan in the middle and deep zones compared to
the superficial zone, enabling the 125I-Fab to enter more quickly from the superficial zone.
The apparent high grain intensity at the very top and bottom surfaces (Fig. 2d) may be due
to adsorption to these surfaces [33]; nevertheless, full penetration of 125I-Fab into the disks
by simple diffusion was clear at day 3, and equilibrium partitioning throughout the depth
could thus occur given sufficient time. Since the Fab did not appear to bind reversibly to
specific sites within the bulk cartilage tissue (see Fig. 3 below), each data point of Fig. 1 can
be interpreted as the integrated sum of 125I-Fab molecules that are distributed in a spatially
non-uniformly profile inside each disk prior to final equilibrium.
Anti-IL-6 Fab fragment did not bind to sites in the bulk of bovine cartilage explants
To determine whether Fab fragment may bind to specific sites within the tissue, graded
amounts of unlabeled Fab were added to the baths during incubation and the uptake ratio
was measured at day 5 [12, 29, 34]. Competition for binding sites between labeled and
unlabeled Fab would cause decreased uptake ratio of 125I-Fab with increasing concentration
of unlabeled Fab. However, the data of Fig. 3 showed no significant change in uptake
of 125I-Fab at either 37°C or 4°C with addition of unlabeled Fab up to 1 μM, indicating
negligible competitive binding between the labeled and unlabeled Fab under these
conditions [29] (2-way ANOVA, no significant effect of unlabeled Fab concentration or the
interaction between temperature and concentration). The same experiment was repeated with
disks from two joints each from two additional animals and showed the same trend as Fig. 3
(data not shown).
Injurious compression and exogenous TNFα altered transport of anti-IL-6 Fab into bovine
knee cartilage
To test the effect of injurious compression alone on transport of Fab fragments into
cartilage, the uptake ratio of 125I-Fab was measured after cartilage explants were subjected
to a single injurious compression cycle. Injurious loading induced a significant increase in
the uptake ratio of 125I-Fab compared to uninjured controls (2-way ANOVA, p<0.0001 for
effect of injury, Fig. 4a). Mechanical injury also caused tissue swelling (Fig. 4b), as
manifested in increased tissue hydration (tissue water weight/dry weight [35, 36], 2-way
ANOVA, p = 0.098 for effect of injury) and water content (2-way ANOVA, p<0.0001 for
effect of injury), consistent with previously reported effects of mechanical injury on
cartilage swelling [20, 21]. These results demonstrated that a single mechanical overload of
cartilage was enough to increase the micro-permeability of the matrix to Fab fragments,
consistent with the increase in macroscopic matrix swelling.
In addition, we tested the effects of exogenous TNFα, alone and combined with mechanical
injury on the uptake of 125I-Fab. Treatment with injury, TNFα, and the combination of
injury and TNFα each significantly increased the uptake ratio of 125I-Fab over 6 days. The
combined effect of injury and TNFα induced the largest increase (post hoc Tukey's test,
p<0.05, Fig. 5a). GAG release from explants to the medium showed a trend similar to the
uptake ratio: mechanical injury and TNFα each significantly increased GAG release, and
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their combination caused the highest GAG loss, consistent with the previously reported
effects of injury and exogenous cytokines on GAG loss [11, 22] (cumulative GAG loss to
the media at day 6 for control, injury, TNFα, and injury with TNFα, was 7.3%, 8.9%,
16.3%, and 16.8%, respectively, data not shown). We also observed changes in tissue
hydration and GAG density (GAG content/tissue water weight) after injury and cytokine
treatment. Tissue hydration was significantly increased by all three treatments compared to
control (Fig. 5b, post hoc Tukey's test, p<0.05), suggesting, again, that the change in tissue
hydration affected the uptake ratio of 125I-Fab. Similarly, GAG density was significantly
decreased after the treatment (2-way ANOVA). This result indicated that the steric
hindrance imposed by tissue GAG was also responsible for the limited uptake of Fab
fragment and the change in the GAG density combined with tissue swelling resulted in the
greatest change in the uptake ratio.
4. Discussion
Our results suggest that Fab fragments (48 kDa) can diffuse into and throughout the depth of
1mm-thick middle zone bovine cartilage disks. Both uptake into bovine cartilage explants
and autoradiography images of human knee cartilage explants suggest that complete
equilibration into full-thickness cartilage would take at least one week. There was
demonstrably greater accessibility of the Fab into the cartilage after direct mechanical injury
and/or treatment with the inflammatory cytokine TNFα, and the increase in uptake was
related to the severity of matrix damage and GAG loss. The combination of mechanical
injury and TNFα induced the most dramatic increase in the uptake, suggesting that changes
in cartilage associated with traumatic joint injury [13, 19], including the immediate
inflammatory response [37], could greatly alter transport processes in cartilage.
Although full-penetration of 125I-Fab into human explant disks was observed in
autoradiography images, the spatial distribution was not uniform. At day 3, significant
penetration of 125I-Fab was detected in the more hydrated surface regions but less in the
middle and deep regions of the disks. Nevertheless, these results suggest that Fab fragments
can reach targets located beyond the superficial zone of cartilage, which is a key
requirement for Fab to be useful as a therapeutic if the target is located throughout the tissue
thickness. In contrast, previous studies have shown that full sized monoclonal antibodies
(mAb, MW ~150 kDa) cannot penetrate into cartilage beyond the top most surface regions
of cartilage due to steric exclusion [6]. Thus, targets deeper within the tissue cannot be
reached by mAbs. For comparison, we show lack of penetration of a fluorescently tagged
anti-IL-6 mAb into native bovine cartilage (Supplementary Fig. S1a). Only when cartilage
GAGs are completely removed (in this case by a 14-day pre-treatment with IL-1 and
oncostatin M (OSM)) can this anti-IL-6 mAb fully penetrate into bovine cartilage (Fig. S1b).
In addition, it is important to note that anti-IL-6 Fab did not appear to bind reversibly to sites
in the bovine cartilage disks (Fig. 3); such binding would have greatly slowed the diffusive
transport of Fab within the cartilage matrix compared to size-restriction alone [12, 34]. For
example, insulin-like growth factor-1 (IGF-1) binds to specific IGF binding proteins
(IGFBPs) contained within cartilage ECM, and the binding of IGF-1 to these IGFBPs slows
diffusive transport kinetics of IGF-1 by a factor of ~ 10 in bovine cartilage [12]. Thus, Fab
can penetrate beyond the surface of the cartilage (Fig. 2) and freely diffuse into the deeper
regions of the tissue at a rate dependent primarily on the local steric hindrance within the
matrix. However, in the absence of binding to sites in the matrix, Fab fragments could
diffuse out of the cartilage at the same rate as they diffuse in, once the Fab had been cleared
from synovial fluid by the circulation [38, 39] and the inward concentration gradient was no
longer sustained. Thus, the absence of binding to sites in the ECM is beneficial for achieving
Byun et al. Page 7
Arch Biochem Biophys. Author manuscript; available in PMC 2014 April 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
deeper penetration in given time, but a mechanisms for sustained delivery within cartilage
and intratissue release is also needed [29, 40].
Assuming no binding of Fab fragments to sites in the tissue (based on the data of Fig. 3), the
diffusivity D and partition coefficient K in our specimens can be estimated from the
measured uptake ratio. As an example, the temporal increase in uptake ratio measured under
free-swelling conditions of Fig. 4A (both untreated and post-mechanical injury) was fitted
using a two-dimensional axisymmetric diffusion model, assuming that diffusion into the
cartilage disk occurred from all surfaces (since the multi-well plates were constantly mixed).
The diffusivity and partition coefficient of Fab fragments into untreated disks were
estimated to be D = 3.5×10−9 cm2/s and K = 0.09, respectively. For mechanically injured
disks, the diffusivity and partition coefficient increased by ~ 30% and ~ 40%, respectively.
For comparison, the diffusivity and partition coefficient of 40 kDa dextran in human and
animal cartilages have been reported previously to be in the ranges D ~ 1×10−8 to 6×10−8
cm2/s and K ~ 0.03–0.3, respectively [8–10].
We also observed that the uptake ratio measured at 37°C was higher than that at 4°C (Fig.
3). Previously, Torzilli used glucose and dextran (10 kDa) to test the effect of temperature
on transport into adult bovine cartilage [41]. Increasing the temperature from 10°C to 37°C
induced a significant increase in diffusivities and partition coefficients of glucose and
dextran, suggesting that the uptake of Fab could be similarly affected by temperature. Fab
uptake was indeed higher at 37° compared to 4° (Fig. 3). However, the uptake of
radiolabeled Fab did not change with the addition of substantial amounts of unlabeled Fab,
further supporting the conclusion that there is little or no binding of Fab to sites in the tissue.
Interestingly, Fab diffused more freely into the tissue following mechanical injury of the
matrix. Mechanical loading as used in the present study induced tissue swelling, as
demonstrated by the increase in tissue hydration and tissue water content (Fig. 4b). Such
tissue swelling is likely caused by micro-damage to the collagen fibril network which
ordinarily restricts the osmotic swelling generated by highly charged GAG chains [42]. The
increased hydration and tissue water content following mechanical injury would allow Fab
to move with less hindrance within the cartilage, resulting in an increased uptake ratio (e.g.,
Fig. 4). Compared to the middle zone, which was used throughout the current study, the
superficial zone is even more vulnerable to the compressive mechanical injury, showing
more matrix disruption and GAG loss [43]. Therefore, following traumatic joint injury and
the associated damage to cartilage, changes in the uptake of Fab or similarly-sized
molecules into the superficial zone may be even more significant than that in the middle
zone.
TNFα treatment combined with mechanical injury further increased uptake of Fab,
suggesting that the inflammatory response following joint injury can play a critical role in
altering the transport properties of damaged cartilage. It is well known that GAG density
plays a major role in restricting the penetration of large solutes, such as Fab fragments (48
kDa). Cytokine treatment of bovine cartilage disks resulted in increased GAG release, and
the highest GAG loss was caused by the combination of mechanical injury and cytokine
insult, as previously reported [11]. Thus, the observed increase in Fab uptake due to injury
plus cytokine treatment (Fig. 5) is likely due to the combined increase in tissue hydration
and decrease in GAG density. These findings are consistent with several previous reports
regarding the effects of zonal GAG density, enzymatic digestion, and static compression
showed significant changes in the solute transport of large molecules, such as serum
albumin (69 kDa), transferrin (76 kDa), and dextrans (40 kDa and 70 kDa) [6, 14, 44].
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The in vitro injury model used in the present study was established to characterize and
understand the effects of cartilage injury as a risk factor for cartilage degradation, relevant to
the progression of OA [11, 22]. Using the same model, Sui et al. showed that anti-IL-6 Fab
fragments significantly reduced the aggrecan degradation induced by mechanical injury and
TNFα [11], suggesting that an anti-cytokine strategy could potentially be applied to
treatment of joint trauma and the risk of post traumatic OA. Here we quantified the transport
of an anti-IL-6 Fab fragment into cartilage to test the practical use of Fab as a therapeutic
against intratissue targets.
In addition, Sui et al. [11] showed that the mechanical injury potentiated aggrecan
catabolism mediated by TNFα and IL-6/sIL-6R, and hypothesized that altered transport
associated with injury could facilitate entry of inflammatory cytokines and proteases
involved in cartilage degradation. Although the transport of TNFα, IL-6, and other
inflammatory mediators was not studied in the present work, the results of this study indeed
support the importance of transport in the kinetics of catabolic processes following cartilage
damage caused by traumatic joint injury. If the solute(s) of interest interacts with specific
binding sites within the cartilage, changes in transport kinetics after the joint injury would be
further affected by solute-matrix binding, since the distribution of such sites could also
undergo significant change.
Penetration of Fab fragments into damaged cartilage subjected to mechanical injury and
TNFα was measured under 10% static compression, which only allowed transport of 125I-
Fab into cartilage disks in the radial direction (as depicted in Fig. 5), whereas transport into
free-swelling disks (Figs. 1–4) allowed diffusion in both radial and axial directions. Leddy et
al. used 3 kDa and 500 kDa dextrans to study the possibility of anisotropic diffusion in
porcine cartilage mediated by collagen fibril orientation [45]; however, they found no such
diffusion anisotropy in the middle zone in which collagen is randomly oriented. These
results suggest that in our middle zone bovine specimens, diffusion would be similar in the
radial and axial directions.
In summary, this study validates for the first time the transport into cartilage of Fab
fragments as a putative molecular therapy, in this case against IL-6. Fab can penetrate and
diffuse into cartilage, overcoming the limited usefulness of mAb in treating targets fully
within cartilage tissue (e.g., molecules, cell receptors, etc.). Uptake of such therapeutics
would likely be affected by joint injury and the associated inflammatory response, leading to
the entry of catabolic cytokines into cartilage from the synovium and other surrounding joint
tissues. Although our study of the effects of injury and cytokines on transport was limited to
the 48 kDa Fab fragment, it is possible to predict that the transport of other similarly-sized
proteins, including growth factors, cytokines, and matrix molecules, would be affected by
similar traumatic injury to cartilage. Therefore, the present study suggests that mechanical
injury and inflammatory cytokines could further affect cellular activities via altering
transport properties of cartilage matrix, since cell metabolism relies on various solutes that
diffuse through the tissue. We suggest that therapeutics against specific molecular targets
using smaller-sized molecules such as Fab fragments could be more efficacious than full-
size mAb in limiting cartilage degradation caused by traumatic joint injury, due to the ability
of Fab fragments to fully penetrate cartilage.
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Refer to Web version on PubMed Central for supplementary material.
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We validated the transport of Fab fragments into cartilage as a putative therapy.
Fab fragments against IL-6 can penetrate into and throughout cartilage tissue.
Binding of anti-IL-6 Fab fragments to sites in cartilage matrix was negligible.
Mechanical injury of cartilage tissue increased the uptake of Fab fragments.
TNFα treatment combined with mechanical injury further increased the uptake of Fab.
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Figure 1.
Uptake ratio of 125I-Fab in bovine calf cartilage disks incubated at 4°C under free-swelling
conditions without unlabeled Fab in 1×PBS with 0.1% BSA, 0.01% sodium azide, and
protease inhibitors. Mean ± SEM (n = 5–6 disks at each time point, harvested from 2 joints).
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Figure 2.
Autoradiography images of 125I-Fab distributed within human knee cartilage explants at day
3. Cartilage disks were harvested from first ~ 800 μm layer of grade 0–1 human knee
cartilage including the intact superficial zone. Free-swelling cartilage disks were incubated
in medium containing 125I-Fab without unlabeled Fab at 37°C for 3 days in 1×PBS with
0.1% BSA, 0.01% sodium azide, and protease inhibitors. The 125I-Fab penetrated
throughout the human tissue but still exhibited a pronounced gradient in grain density with
depth at day 3, showing a more concentrated distribution of 125I-Fab in the upper region
near the surface (A), compared to that approximately 500–600 μm below the surface (B).
Distribution of 125I-Fab across the full thickness from the same disk (C) was consistent with
higher magnification images (A, B), showing the gradient in the grain intensity throughout
the thickness (D, relative grain intensity measured from C). Scale bars = 100 μm.
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Figure 3.
Concentration-dependent uptake ratio of 125I-Fab in bovine calf cartilage after 5 days under
free swelling conditions at 4°C and 37°C. Graded amounts of unlabeled Fab (0, 10, 100, and
1000 nM) were added to a fixed concentration of 125I-Fab (5.01 nM at 4°C and 2.21 nM at
37°C). At both temperatures, the uptake ratio of 125I-Fab did not change significantly with
the concentration of unlabeled Fab (2-way ANOVA, p=0.495). The uptake ratio of 125I-Fab
was significantly higher at 37°C compared to 4°C (2-way ANOVA, p<0.0001). Mean ±
SEM (n = 4–5 disks for each condition, harvested from 2 joints).
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Figure 4.
Effect of the mechanical injury on the uptake ratio of 125I-Fab and tissue swelling. Untreated
and injured disks were incubated under free swelling conditions up to 6 days with 125I-Fab
without unlabeled Fab at 4°C in 1×PBS with 0.1% BSA, 0.01% sodium azide, and protease
inhibitors. A. Uptake ratio of 125I-Fab in untreated (FS) and injured (INJ) disks. Mechanical
injury induced a significant increase in the uptake ratio (2-way ANOVA, p<0.0001 for both
injury and time, * = p<0.05 by Tukey's test). B. Hydration (tissue water weight/dry weight)
and water content in untreated (FS) and injured (INJ) disks. Tissue water content changed
significantly after the injury (2-way ANOVA, p<0.0001 with injury), accompanied by an
increase in hydration (2-way ANOVA, p=0.098 with injury). Mean ± SEM (n = 8 disks for
each condition, harvested from 2 joints).
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Figure 5.
Effect of the injurious compression and exogenous TNFα on the uptake of 125I-Fab, tissue
hydration, and GAG density. Cartilage disks were subjected to mechanical injury (INJ),
TNFα (TNF), or the combination of injury and TNFα (INJ+TNF), with TNF concentration
at 2.5 ng/ml for day 0–2 and then 25 ng/ml for day 2–6. The disks were incubated at 37°C
with 125I-Fab and unlabeled Fab (10 μg/ml = 66.7 nM) in DMEM with 0.1% BSA, and 1%
ITS under 10% offset static compression so that only radial diffusion could occur from the
bath to the disk center (inset in A). A. Uptake ratio of 125I-Fab measured after 2, 4, and 6
days in culture. Uptake varied significantly with the treatment (2-way ANOVA, p<0.0001
for both treatment and time, * = p<0.05 vs. CTRL by Tukey's test, ‡ = p<0.05 vs. INJ+TNF
by Tukey's test). B. Hydration (tissue water weight/dry weight) of cartilage tissue was
significantly increased by the treatment (2-way ANOVA, p<0.0001 for the treatment, * =
p<0.05 vs. CTRL by Tukey's test). C. GAG density (GAG content / water content) of
cartilage disks was significantly decreased after the treatment (2-way ANOVA, p=0.042 for
the treatment, * = p<0.05 vs. CTRL by Tukey's test). Mean ± SEM (n = 5 disks for each
condition, harvested from 2 joints).
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